Revisiting neutrophil gelatinase-associated lipocalin (ngal) in cancer: saint or sinner?

HIGHLIGHTS

• who: Brigitte Bauvois and Santos A. Susin from the Sorbonne Universités Paris Cité, Paris, France have published the paper: Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Cancer: Saint or Sinner?, in the Journal: Cancers 2018, 10, 336 of /2018/
• future: And Future Directions growing body of evidence suggesting that NGAL overexpression in tumors results from stimuli 7 of 13 7 of 13 and Future Directions remain to be identified.

SUMMARY

The intention of this Article is: (i) to evaluate the positive or negative effects of free NGAL observed in various . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.